The article “SSRI Sexual Dysfunction Label Petition Was Unanswered, Suit Says” by Shweta Watwe has reported on the FDA lawsuit that took place after 6 years of ignorance. Despite posting the petition in 2018 for public comment, the FDA still hasn’t granted or denied it.
Bloomberg Law: SSRI Sexual Dysfunction Label Petition Was Unanswered, Suit Says
Previous
Previous
Reuters: FDA sued by scientist urging sexual side effects warning for widely used depression drugs
Next
Next

